Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer.

ABSTRACT: Prostate cancer (PCa) is the second most common cancer in men worldwide and the most frequently diagnosed cancer among men in more developed countries. The prognosis of PCa is excellent if detected at an early stage, making early screening crucial for detection and treatment. In recent years, a new form of diffusion magnetic resonance imaging called correlated diffusion imaging (CDI) was introduced, and preliminary results show promise as a screening tool for PCa. In the largest study of its kind, we investigate the relationship between PCa presence and a new variant of CDI we term synthetic correlated diffusion imaging (CDI[Formula: see text]), as well as its performance for PCa delineation compared to current standard MRI techniques [T2-weighted (T2w) imaging, diffusion-weighted imaging

SUBMITTER: Wong A 

PROVIDER: S-EPMC8888633 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature